Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BRAMLET, D.
Right arrow Articles by BENDER, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BRAMLET, D.
Right arrow Articles by BENDER, J.
NEUROLOGY 1976;26:287
© 1976 American Academy of Neurology

Meningeal carcinomatosis

Case report and review of the literature DEAN BRAMLET, B.A., JOSEPH GILIBERTI, M.D. and JOHN BENDER, M.D.

From the Rockford School of Medicine, University of Illinois, Rockford, Illinois.

Untreated meningeal carcinomatosis is a uniformly fatal type of metastatic disease presenting with many protean signs and symptoms. We achieved significant palliation and long-term survival in our patient, using combined chemotherapy and radiotherapy; responses to both intrathecal methotrexate and experimental oral CCNU were observed.

Dr. Bender's address is Neurological Section, Rockford School of Medicine, University of Illinois, Rockford, IL 61103.

Received for publication June 25, 1975.




This article has been cited by other articles:


Home page
 Arch NeurolHome page
E. Shuttleworth and N. Allen
CSF {beta}-Glucuronidase Assay in the Diagnosis of Neoplastic Meningitis
Arch Neurol, November 1, 1980; 37(11): 684 - 687.
[Abstract] [PDF]